Literature DB >> 17618546

Medical treatment of endocarditis.

Elias Abrutyn1, Christopher H Cabell, Vance G Fowler, Bruno Hoen, José M Miro, Carlos A Mestres, Daniel J Sexton, G Ralph Corey.   

Abstract

Infective endocarditis (IE) remains a serious and deadly disease. The incidence, which varies by gender and on the presence of predisposing factors, has not decreased, due in part to the aging population with more healthcare exposures and predisposing risk factors such as prosthetic heart valves and intracardiac devices. The most important aspects of treatment in IE hinge upon early diagnosis, microorganism identification with susceptibility testing, and early initiation of appropriate antibiotic therapy. In addition, echocardiographic imaging is critical for both diagnostic and prognostic purposes. Early evaluation for surgery should be considered. Once a therapeutic strategy is begun, careful attention to the clinical course is necessary to ensure appropriate response to therapy and to identify complications early.

Entities:  

Year:  2007        PMID: 17618546     DOI: 10.1007/s11908-007-0043-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  70 in total

1.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.

Authors:  F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

2.  Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group.

Authors:  D J Sexton; M J Tenenbaum; W R Wilson; J M Steckelberg; A D Tice; D Gilbert; W Dismukes; R H Drew; D T Durack
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial.

Authors:  E Ribera; J Gómez-Jimenez; E Cortes; O del Valle; A Planes; T Gonzalez-Alujas; B Almirante; I Ocaña; A Pahissa
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

4.  Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database.

Authors:  T Lalani; Z A Kanafani; V H Chu; L Moore; G R Corey; P Pappas; C W Woods; C H Cabell; B Hoen; C Selton-Suty; T Doco-Lecompte; C Chirouze; D Raoult; J M Miro; C A Mestres; L Olaison; S Eykyn; E Abrutyn; V G Fowler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-06       Impact factor: 3.267

5.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

6.  Successful use of oral linezolid as a single active agent in endocarditis unresponsive to conventional antibiotic therapy.

Authors:  V Ravindran; J John; G C Kaye; R E Meigh
Journal:  J Infect       Date:  2003-08       Impact factor: 6.072

Review 7.  Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study.

Authors:  H Hogevik; L Olaison; R Andersson; J Lindberg; K Alestig
Journal:  Medicine (Baltimore)       Date:  1995-11       Impact factor: 1.889

8.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

9.  Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  George Sakoulas; Pamela A Moise-Broder; Jerome Schentag; Alan Forrest; Robert C Moellering; George M Eliopoulos
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

Authors:  T S J Elliott; J Foweraker; F K Gould; J D Perry; J A T Sandoe
Journal:  J Antimicrob Chemother       Date:  2004-11-16       Impact factor: 5.790

View more
  1 in total

1.  Prosthetic valve endocarditis due to Actinomyces neuii successfully treated with antibiotic therapy.

Authors:  Sebastian Grundmann; Johannes Huebner; Judith Stuplich; Andrea Koch; Kezhong Wu; Anette Geibel-Zehender; Christoph Bode; Michael Brunner
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.